← Open Payments lookup

GREGORY BAKER: Open Payments

NPI 1205924222 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,212 in 187 payments from 29 companies in 2025. Trend: 2023 $4,098 · 2024 $3,428 · 2025 $4,212

Food & beverage: $4,121Education: $91
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.19$642
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$573
AstraZeneca Pharmaceuticals LP14$334
Otsuka America Pharmaceutical, Inc.15$267
Lundbeck LLC15$263
PFIZER INC.7$246
Aimmune Therapeutics, Inc.16$225
Amgen Inc.8$206
Merck Sharp & Dohme LLC9$205
E.R. Squibb & Sons, L.L.C.9$181

Products named: CAPLYTA, UZEDY, REXULTI, ZENPEP, VERQUVO, NURTEC ODT, Repatha, CAMZYOS.

Industry payments across CA — which companies pay providers there.